Black Rock Inc. Lantern Pharma Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LTRN
# of Institutions
34Shares Held
2.37MCall Options Held
17.1KPut Options Held
1.3K-
Bios Capital Management, LP Fort Worth, TX1.21MShares$5.06 Million5.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.52 Million0.0% of portfolio
-
Cm Management, LLC200KShares$838,0000.77% of portfolio
-
Geode Capital Management, LLC Boston, MA90.5KShares$379,2110.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny88.8KShares$372,0720.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $45.4M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...